The data has shown the product to be well tolerated and efficacious in certain age groups and at certain time points.
SkinBioTherapeutics' Cath O'Neill 'thrilled' with human study data for skin cream
Quick facts: SkinBioTherapeutics PLC
Price: 19.5 GBX
Market Cap: £24.98 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of SkinBioTherapeutics PLC named herein, including the promotion by the Company of SkinBioTherapeutics PLC in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE